CEBPZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.167400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.529200E-01
Normal-vs-Stage2
7.821200E-01
Normal-vs-Stage3
2.844800E-01
Normal-vs-Stage4
1.186440E-01
Stage1-vs-Stage2
8.921000E-01
Stage1-vs-Stage3
1.298630E-01
Stage1-vs-Stage4
8.882400E-02
Stage2-vs-Stage3
8.853600E-02
Stage2-vs-Stage4
1.212440E-01
Stage3-vs-Stage4
1.017760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.186400E-01
Normal-vs-AfricanAmerican
4.145000E-01
Normal-vs-Asian
7.646800E-01
Caucasian-vs-AfricanAmerican
2.045200E-01
Caucasian-vs-Asian
2.962400E-01
AfricanAmerican-vs-Asian
1.291980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.191600E-01
Normal-vs-Female
8.074200E-01
Male-vs-Female
8.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.279400E-01
Normal-vs-Age(41-60Yrs)
4.566600E-01
Normal-vs-Age(61-80Yrs)
9.674200E-01
Normal-vs-Age(81-100Yrs)
6.310600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.130200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.272400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.526600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.501800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.098600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.280600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.489200E-01
Normal-vs-Daily Drinker
9.643200E-01
Normal-vs-Weekly Drinker
7.454000E-01
Normal-vs-Occasional Drinker
3.711200E-01
Normal-vs-Social Drinker
6.862600E-01
Non Drinker-vs-Daily Drinker
9.970400E-01
Non Drinker-vs-Weekly Drinker
5.298400E-01
Non Drinker-vs-Occasional Drinker
7.969800E-02
Non Drinker-vs-Social Drinker
3.187200E-01
Daily Drinker-vs-Weekly Drinker
6.243800E-01
Daily Drinker-vs-Occasional Drinker
1.646850E-01
Daily Drinker-vs-Social Drinker
4.428200E-01
Weekly Drinker-vs-Occasional Drinker
8.290400E-02
Weekly Drinker-vs-Social Drinker
2.314200E-01
Occasional Drinker-vs-Social Drinker
6.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.525610E-01
Normal-vs-Grade 2
2.853600E-02
Normal-vs-Grade 3
1.343740E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.184300E-02
Grade 1-vs-Grade 3
5.757900E-03
Grade 1-vs-Grade 4
1.525610E-01
Grade 2-vs-Grade 3
1.462970E-01
Grade 2-vs-Grade 4
2.853600E-02
Grade 3-vs-Grade 4
1.343740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.464000E-01
Normal-vs-NonDiabetic
9.219600E-01
Diabetic-vs-NonDiabetic
6.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.100200E-01
Normal-vs-NoPancreatitis
9.449200E-01
Pancreatitis-vs-NoPancreatitis
7.116000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.115800E-01
Normal-vs-N1
7.799600E-01
N0-vs-N1
8.692600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.219400E-01
Normal-vs-TP53-NonMutant
8.538000E-01
TP53-Mutant-vs-TP53-NonMutant
1.336950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
